Effects of percutaneous balloon mitral valvuloplasty in patients with mitral stenosis and atrial fibrillation: a systematic review and meta-analysis

Liu, Bojiang; Wang, Yunyun; Liu, Yingwu; Wu, Peng; Li, Tong

doi:10.1080/00015385.2021.1989837

Cited by 3 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PBMV is a standard procedure employed for the treatment of symptomatic rheumatic MS across all age groups with a favorable MV anatomy (4)(5)(6). In forty years, not much has changed in terms of the instruments employed; nonetheless, increased procedural safety has been made possible by advances in imaging technology and the field of interventional cardiology.…”

Section: Percutaneous Balloon Mitral Valvotomy Technique In Rheumatic...mentioning

confidence: 99%

See 1 more Smart Citation

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Habib,

Mendel,

Fauzan

et al. 2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Percutaneous balloon mitral valvotomy (PBMV) is a good and preferred therapy choice over surgical commissurotomy for patients with rheumatic mitral stenosis (MS). However, interventional cardiologists must recognize that treating patients with rheumatic MS poses unique challenges for each patient, especially in special populations such as pregnant patients or patients with arrhythmias like atrial fibrillation (AF), which can complicate procedures. Based on information from observational studies, PBMV may be a safe and efficient treatment for improving outcomes in MS women who do not have substantial subvalve illness in a specific demographic. A successful PBMV helps to tolerate hemodynamic changes during pregnancy and dramatically reduces mortality. However, there is a paucity of studies on women with poor valve morphology who are not contraindicated, and it has to be seen if PBMV is used in these situations during pregnancy. Conversely, AF leads to a lower PBMV success rate as well as worse long-term and in-hospital outcomes.

show abstract

Section: Percutaneous Balloon Mitral Valvotomy Technique In Rheumatic...mentioning

confidence: 99%

“…PBMV has better results, a shorter hospital stay, and lower risk than surgical valvotomy. In recent decades, PBMV techniques and safety have also improved (4)(5)(6).…”

Section: Introductionmentioning

confidence: 99%

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Habib,

Mendel,

Fauzan

et al. 2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

Focus on valvular heart disease

et al. 2022

View full text Add to dashboard Cite

Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Atrial Fibrillation and Rheumatic Valve Disease

Silva

Borges

2023

CVP

View full text Add to dashboard Cite

The lifetime risk of developing atrial fibrillation (AF) is 1 in 3 adults, resulting in a prevalence of 2-4%. Rheumatic heart disease (RHD) is a frequent aetiology of valvular heart disease in low- and middle-income countries. Between 21% and 80% of patients with mitral valve disease, especially with stenosis, may have AF. Both these conditions, AF and RHD, present a state of persistent inflammation. In turn, inflammation is a frequent cause of anisocytosis, which can be evidenced through the parameter RDW (red bold cell distribution width). Factors associated with increased RDW are also known as risk factors associated with a higher incidence of AF. RDW may have an independent role in the pathogenesis of AF and the increased propensity of both thromboembolic and bleeding events. Another marker involved in the incidence of AF is the neutrophil-lymphocyte ratio. This is also a marker of oxidative stress and inflammation and is associated with a higher rate of AF recurrence. This review will evaluate these biomarkers and their association with cardiovascular events in patients with AF and RHD. The hypotheses and current debates about the relationship of biomarkers with the severity of chronic valve dysfunction, with acute rheumatic carditis in the paediatric population, and with the presence of thrombus in the left atrium will be discussed.

show abstract

Effects of percutaneous balloon mitral valvuloplasty in patients with mitral stenosis and atrial fibrillation: a systematic review and meta-analysis

Cited by 3 publications

References 30 publications

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Focus on valvular heart disease

Neutrophil-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Atrial Fibrillation and Rheumatic Valve Disease

Contact Info

Product

Resources

About